Faculty profile
Barbara Doumouras
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest funding
- $1,487,925
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2025 · Co-investigator
- $100,000
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2024 · Co-investigator
- $661,724
BREATHe: B-type natriuretic peptides to reduce events and advance treatment in heart failure
CIHR · 2024 · Co-investigator
No publications available.
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
Principal investigators: Abdel-Qadir, Husam-Eldin M; Amir, Eitan
Keywords: Cardiac Imaging; Cardiotoxicity; Echocardiography; Heart Failure; Her-2 Positive Breast Cancer; Left Ventricular Ejection Fraction; Non-Inferiority; Nuclear Imaging; Randomized Controlled Trial; Trastuzumab
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
Principal investigators: Abdel-Qadir, Husam-Eldin M; Amir, Eitan
Keywords: Cardiac Imaging; Cardiotoxicity; Echocardiography; Heart Failure; Her-2 Positive Breast Cancer; Left Ventricular Ejection Fraction; Non-Inferiority; Nuclear Imaging; Randomized Controlled Trial; Trastuzumab
BREATHe: B-type natriuretic peptides to reduce events and advance treatment in heart failure
Principal investigators: Lee, Douglas S
Keywords: Heart Failure; Hospitalization; Laboratory Testing; Outcomes Research; Population Health; Prediction Modeling
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
Principal investigators: Abdel-Qadir, Husam-Eldin M; Amir, Eitan
Keywords: Cardiac Imaging; Cardiotoxicity; Choosing Wisely; Echocardiography; Heart Failure; Her-2 Positive Breast Cancer; Left Ventricular Ejection Fraction; Non-Inferiority; Randomized Controlled Trial; Trastuzumab
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.